Compare · 2 funds side by side · dividends reinvested

PJP and XLV

PJPInvesco×XLVSPDR×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$17,240PJP · best of the two

02 / 04

PJP and XLV, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Invesco Pharmaceuticals ETFSectors · Health care0.58%0.88%+24.5%+34.6%+25.2%+11.5%−9.4%17.6%$579M1.4

State Street Health Care Select Sector SPDR ETFSectors · Health care0.08%1.39%+20.4%+29.7%+16.2%+8.5%−10.5%16.4%$49.1B1.6

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: PJP 2005 · XLV 1998

Head to Head

Swap sides Versus in desk

Head to Head

Invesco Pharmaceuticals ETF · $579M$17,240

PJP

XLV

State Street Health Care Select Sector SPDR ETF · $49.1B$15,068

$10,000 five years ago, dividends reinvested · they hold 38.4% in common

PJPMeasureXLV

+24.5%Year to dateJan 1 → Nov 3+20.4%

+34.6%1 yearTotal return+29.7%

+25.2%3 years · per year$10,000 became $19,628 · $15,709+16.2%

+11.5%5 years · per year$10,000 became $17,240 · $15,068+8.5%

0.58%Expense ratio$58 · $8 a year on $10k · lower is better0.08%

0.88%Trailing 12-mo yield$88 · $139 a year on $10k1.39%

−9.4%Worst dropSmaller is better−10.5%

17.6%VolatilityLower is calmer16.4%

PJPXLV Winner of the row, in its colourEach row: the bigger of the two fills its side

5–3PJP wins

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

PJP vs XLV: Top 5 Holdings

Today

PJP

29.5%in top 5

XLV

in top 545.0%

PJPStockXLV

6.1%LLY16.5%

not top 5JNJ9.9%

5.8%ABBV7.7%

6.1%GILDnot top 5

5.8%PFEnot top 5

5.6%AMGNnot top 5

not top 5UNH5.5%

not top 5MRK5.4%

Held in common38.4%

End-of-day Nov 3, 2026 · share of each fund

PJP vs XLV Returns, Every Period

InvescoPJP

+11.5%

5 years, per year

XLVSPDR

+8.5%

5 years, per year

PJPXLVFaded: behind in that period

4–0PJP wins

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

PJP vs XLV

YTD

InvescoPJP

+24.5%

XLVSPDR

+20.4%

+24.5%Year to date+20.4%

−9.4%Worst drop · 1Y−10.5%

17.6%Volatility · 1Y16.4%

0.9%Yield1.4%

$579MAssets$49.1B

2–2level

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: PJP, XLV

Today

0.08%lowest, XLV

FundExpense ratioFee$10k

XLV0.08%$8

PJP0.58%$58

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: PJP, XLV

1.39%highest, XLV

FundTrailing yieldYield$10k

XLV1.39%$139

PJP0.88%$88

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

$131most kept, XLV

XLV$139 − $8 = $131

PJP$88 − $58 = $30

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: PJP, XLV

Today

38.4%most shared, PJP and XLV

PJPXLV

PJP—38.4%

XLV38.4%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+34.6%PJP, at 17.6% volatility

XLVWorst drop−10.5%16.4% vol

PJPWorst drop−9.4%17.6% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

XLVPJP

+20.4%Year to date+24.5%

1.4%Yield0.9%

+29.7%Past year+34.6%

0.08%Fee0.58%

2–2level

End-of-day Nov 3, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.5%

JEPIJ.P. Morgan

+7.0%

+7.5%Year to date+7.0%

12.3%Yield8.0%

$41.8BAssets$46.0B

2–0JEPQ wins

End-of-day Nov 3, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026